Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1)

TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1

(2017) C Wang et al.   Oncogenesis

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis

(2016) C. S. Tellez et al.   CANCER RESEARCH

MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression

(2016) Agustí Toll et al.   Molecular Cancer

miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4

(2016) Lifen Zhao et al.   ONCOLOGY REPORTS

Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel

(2016) Mahesh Tambe et al.   Oncotarget

Epigenetic alternations and cancer chemotherapy response

(2015) Jin-Feng Lv et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells

(2014) Hiroaki Sakai et al.   CANCER SCIENCE

TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells

(2014) Xiaorong Liu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Involvement of microRNA-24 and DNA Methylation in Resistance of Nasopharyngeal Carcinoma to Ionizing Radiation

(2014) S. Wang et al.   MOLECULAR CANCER THERAPEUTICS

MicroRNA-493 Suppresses Tumor Growth, Invasion and Metastasis of Lung Cancer by Regulating E2F1

(2014) Yixue Gu et al.   PLoS One

The emerging role of miR-375 in cancer

(2013) Jun-Wei Yan et al.   INTERNATIONAL JOURNAL OF CANCER

Cancer Development, Progression, and Therapy: An Epigenetic Overview

(2013) Sibaji Sarkar et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis

(2013) Sichuan Xi et al.   JOURNAL OF CLINICAL INVESTIGATION

KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling

(2013) Klaus W. Wagner et al.   JOURNAL OF CLINICAL INVESTIGATION

Epigenetic biomarkers in lung cancer

(2012) Triantafillos Liloglou et al.   CANCER LETTERS

miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver

(2012) Koji Okamoto et al.   EMBO JOURNAL

Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma

(2012) Bo Peng et al.   PLoS One

Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line

(2011) Yixue Gu et al.   FEBS LETTERS

TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway

(2011) Yixue Gu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Tumor Suppressor MicroRNA-493 Decreases Cell Motility and Migration Ability in Human Bladder Cancer Cells by Downregulating RhoC and FZD4

(2011) K. Ueno et al.   MOLECULAR CANCER THERAPEUTICS

DNA methylation of tumor suppressor miRNA genes: a lesson from themiR-34family

(2011) Kwan Yeung Wong et al.   Epigenomics

Lung cancer

(2010) Arnaud Van Den Broeck et al.   Cell Adhesion & Migration

Genetic and epigenetic heterogeneity in cancer: A genome-centric perspective

(2009) Henry H.Q. Heng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Epigenetics in cancer: Targeting chromatin modifications

(2009) L. Ellis et al.   MOLECULAR CANCER THERAPEUTICS

Kinetics of H2AX phosphorylation after exposure to cisplatin

(2008) Peggy L. Olive et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY